世界の女性用性的欲求低下障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2332 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、女性用性的欲求低下障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他）、用途別市場規模（外来、入院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・女性用性的欲求低下障害治療の市場動向 ・企業の競争状況、市場シェア ・女性用性的欲求低下障害治療の種類別市場規模（BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他） ・女性用性的欲求低下障害治療の用途別市場規模（外来、入院） ・女性用性的欲求低下障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・女性用性的欲求低下障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性用性的欲求低下障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性用性的欲求低下障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性用性的欲求低下障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Emotional Brain BV、GlaxoSmithKline Plc、Palatin Technologies Inc、Pivot Pharmaceuticals Inc、Strategic Science & Technologies LLC） ・結論

Market Analysis and Insights: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market
The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Female Hypoactive Sexual Desire Disorder Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Female Hypoactive Sexual Desire Disorder Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Female Hypoactive Sexual Desire Disorder Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Female Hypoactive Sexual Desire Disorder Therapeutics market.

Global Female Hypoactive Sexual Desire Disorder Therapeutics Scope and Market Size
Female Hypoactive Sexual Desire Disorder Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Hypoactive Sexual Desire Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
BP-101
Bremelanotide
Gepirone Hydrochloride ER
PVT-011
Others

Segment by Application
Out-Patient
In-Patient

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Emotional Brain BV
GlaxoSmithKline Plc
Palatin Technologies Inc
Pivot Pharmaceuticals Inc
Strategic Science & Technologies LLC

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 BP-101
1.2.3 Bremelanotide
1.2.4 Gepirone Hydrochloride ER
1.2.5 PVT-011
1.2.6 Others
1.3 Market by Application
1.3.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Out-Patient
1.3.3 In-Patient
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Perspective (2016-2027)
2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Growth Trends by Regions
2.2.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Industry Dynamic
2.3.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Trends
2.3.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market Drivers
2.3.3 Female Hypoactive Sexual Desire Disorder Therapeutics Market Challenges
2.3.4 Female Hypoactive Sexual Desire Disorder Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Revenue
3.1.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue
3.4 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2020
3.5 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Female Hypoactive Sexual Desire Disorder Therapeutics Breakdown Data by Type
4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Type (2022-2027)

5 Female Hypoactive Sexual Desire Disorder Therapeutics Breakdown Data by Application
5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2016-2027)
6.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type
6.2.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2027)
6.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application
6.3.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2027)
6.4 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country
6.4.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2016-2027)
7.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type
7.2.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2027)
7.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application
7.3.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2027)
7.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country
7.4.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type
8.2.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application
8.3.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region
8.4.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2016-2027)
9.2 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type
9.2.1 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application
9.3.1 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country
9.4.1 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type
10.2.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application
10.3.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country
10.4.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Emotional Brain BV
11.1.1 Emotional Brain BV Company Details
11.1.2 Emotional Brain BV Business Overview
11.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
11.1.4 Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
11.1.5 Emotional Brain BV Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 Palatin Technologies Inc
11.3.1 Palatin Technologies Inc Company Details
11.3.2 Palatin Technologies Inc Business Overview
11.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
11.3.4 Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
11.3.5 Palatin Technologies Inc Recent Development
11.4 Pivot Pharmaceuticals Inc
11.4.1 Pivot Pharmaceuticals Inc Company Details
11.4.2 Pivot Pharmaceuticals Inc Business Overview
11.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
11.4.4 Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
11.4.5 Pivot Pharmaceuticals Inc Recent Development
11.5 Strategic Science & Technologies LLC
11.5.1 Strategic Science & Technologies LLC Company Details
11.5.2 Strategic Science & Technologies LLC Business Overview
11.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
11.5.4 Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
11.5.5 Strategic Science & Technologies LLC Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of BP-101
Table 3. Key Players of Bremelanotide
Table 4. Key Players of Gepirone Hydrochloride ER
Table 5. Key Players of PVT-011
Table 6. Key Players of Others
Table 7. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Regions (2022-2027)
Table 13. Female Hypoactive Sexual Desire Disorder Therapeutics Market Trends
Table 14. Female Hypoactive Sexual Desire Disorder Therapeutics Market Drivers
Table 15. Female Hypoactive Sexual Desire Disorder Therapeutics Market Challenges
Table 16. Female Hypoactive Sexual Desire Disorder Therapeutics Market Restraints
Table 17. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics as of 2020)
Table 20. Ranking of Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service
Table 24. Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Emotional Brain BV Company Details
Table 65. Emotional Brain BV Business Overview
Table 66. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product
Table 67. Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Emotional Brain BV Recent Development
Table 69. GlaxoSmithKline Plc Company Details
Table 70. GlaxoSmithKline Plc Business Overview
Table 71. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product
Table 72. GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Plc Recent Development
Table 74. Palatin Technologies Inc Company Details
Table 75. Palatin Technologies Inc Business Overview
Table 76. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product
Table 77. Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Palatin Technologies Inc Recent Development
Table 79. Pivot Pharmaceuticals Inc Company Details
Table 80. Pivot Pharmaceuticals Inc Business Overview
Table 81. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product
Table 82. Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Pivot Pharmaceuticals Inc Recent Development
Table 84. Strategic Science & Technologies LLC Company Details
Table 85. Strategic Science & Technologies LLC Business Overview
Table 86. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product
Table 87. Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Strategic Science & Technologies LLC Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. BP-101 Features
Figure 3. Bremelanotide Features
Figure 4. Gepirone Hydrochloride ER Features
Figure 5. PVT-011 Features
Figure 6. Others Features
Figure 7. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Out-Patient Case Studies
Figure 9. In-Patient Case Studies
Figure 10. Female Hypoactive Sexual Desire Disorder Therapeutics Report Years Considered
Figure 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Players in 2020
Figure 16. Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2020
Figure 18. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Region (2016-2027)
Figure 40. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Emotional Brain BV Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
Figure 61. Palatin Technologies Inc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
Figure 62. Pivot Pharmaceuticals Inc Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
Figure 63. Strategic Science & Technologies LLC Revenue Growth Rate in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---